Is Johnson & Johnson Stock A Better Pick Over AbbVie?
9/4 07:25
We believe that the pharmaceuticals bellwether Johnson & Johnson (NYSE: JNJ) is currently a better pick over its peer AbbVie (NYSE: ABBV). AbbVie trades at a higher valuation of 5.5x trailing revenues, compared to 4.6x for JNJ. However, we think that this valuation gap w...